Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
8,460.00
+110.00 (1.32%)
Oct 28, 2026, 2:50 PM KST
KRX:019170 Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 239,065 | 234,681 | 221,094 | 200,229 | 209,288 | 189,237 |
Revenue Growth | 6.21% | 6.14% | 10.42% | -4.33% | 10.60% | -4.30% |
Gross Profit Gross Profit Growth | 102,102 | 102,671 | 81,804 | 80,277 | 77,973 | 77,388 |
Operating Income Operating Income Growth | 2,692 | 14,255 | -17,029 | -47,392 | -34,019 | -14,306 |
Net Income Net Income Growth | -1,187 | 8,454 | -15,387 | -57,325 | -35,377 | -11,584 |
Earnings Per Share EPS Growth | -23.03 | 164.91 | -300.17 | -1118.28 | -690.12 | -225.97 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Vietnam Vietnam Growth | 16,534 | 16,235 | 15,824 | 13,929 | - | - |
South Korea South Korea Growth | 169,364 | 168,889 | 164,243 | 160,315 | 196,169 | 179,784 |
Myanmar Myanmar Growth | 3,555 | 3,626 | 3,400 | 1,293 | - | - |
Philippines Philippines Growth | 2,246 | 2,239 | 1,898 | 1,816 | - | - |
Japan Japan Growth | 21,324 | 22,990 | 20,707 | 12,891 | - | - |
Others Others Growth | 26,043 | 20,702 | 15,022 | 9,985 | - | - |
Total Total Growth | 239,065 | 234,681 | 221,094 | 200,229 | 209,288 | 189,237 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 72,308 | 71,506 | 56,461 | 60,581 | 55,917 | 92,702 |
Total Debt Total Debt Growth | 53,281 | 55,856 | 54,597 | 46,151 | 1,928 | 1,181 |
Net Cash (Debt) Net Cash Growth | 19,027 | 15,650 | 1,864 | 14,430 | 53,988 | 91,521 |
Net Cash Growth | 404.17% | 739.66% | -87.08% | -73.27% | -41.01% | -51.54% |
Net Cash Per Share Net Cash Per Share Growth | 369.21 | 305.30 | 36.36 | 281.49 | 1053.18 | 1785.35 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17,569 | 17,254 | -15,155 | -24,808 | -26,444 | -71,028 |
Capital Expenditures CapEx Growth | -3,995 | -3,477 | -5,569 | -14,888 | -5,323 | -4,425 |
Free Cash Flow Free Cash Flow Growth | 13,574 | 13,776 | -20,724 | -39,696 | -31,767 | -75,453 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.71% | 43.75% | 37.00% | 40.09% | 37.26% | 40.89% |
Operating Margin | 1.13% | 6.07% | -7.70% | -23.67% | -16.25% | -7.56% |
Pretax Margin | 0.00% | 3.60% | -6.61% | -26.69% | -16.62% | -4.75% |
Profit Margin | -0.50% | 3.60% | -6.96% | -28.63% | -16.90% | -6.12% |
FCF Margin | 5.68% | 5.87% | -9.37% | -19.82% | -15.18% | -39.87% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 87.37 | - | - | - | - |
P/FCF Ratio | 33.71 | 53.61 | - | - | - | - |
PS Ratio | 1.91 | 3.15 | 2.44 | 3.53 | 5.38 | 8.74 |